Prenatal diagnosis · 2026
Genetic Investigation of Pregnancies With an Isolated Fetal Pelvic Kidney.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Qiu-Xia, Zhen Li, Tain Qi, Li Si-Yun, Guo Jia-Chun, Zhang Yong-Ling, Li Dong-Zhi
Аннотация
OBJECTIVE: To explore genetic investigative results in fetuses with isolated pelvic kidney.
METHODS: This was a retrospective study of 212 fetuses with isolated pelvic kidney diagnosed on second trimester anatomy ultrasound. All cases underwent invasive prenatal diagnosis for copy number variant (CNV) detection by chromosomal microarray analysis (CMA). For those with a negative CNV, trio exome sequencing (ES) was an option. Clinical and laboratory data were collected and reviewed for these cases, including maternal demographics, prenatal sonographic findings, molecular testing results, and pregnancy outcomes.
RESULTS: In total, 212 cases underwent CMA testing, which identified one case of pathogenic CNV, specifically a de novo 16p11.2 microdeletion. Among the cases that yielded negative results from CMA, 118 proceeded to trio ES. Five (4.2%; 5/118) disease-causing variants across five unrelated fetuses, involving four genes: DLL1, KMT2D, PTEN and PRKG1, with two cases harboring distinct pathogenic variants in KMT2D. Following rigorous phenotype-genotype correlation assessment, only the two KMT2D variants were deemed clinically attributable, resulting in an attributable diagnostic yield of 1.7% (2/118). The remaining three variants were classified as incidental findings. With the exception of the PRKG1 variant, which was inherited from the mother, the remaining four variants were confirmed as de novo.
CONCLUSION: Our results should raise clinical awareness among obstetricians and maternal-fetal medicine specialists regarding the potential syndromic associations of pelvic kidney.
METHODS: This was a retrospective study of 212 fetuses with isolated pelvic kidney diagnosed on second trimester anatomy ultrasound. All cases underwent invasive prenatal diagnosis for copy number variant (CNV) detection by chromosomal microarray analysis (CMA). For those with a negative CNV, trio exome sequencing (ES) was an option. Clinical and laboratory data were collected and reviewed for these cases, including maternal demographics, prenatal sonographic findings, molecular testing results, and pregnancy outcomes.
RESULTS: In total, 212 cases underwent CMA testing, which identified one case of pathogenic CNV, specifically a de novo 16p11.2 microdeletion. Among the cases that yielded negative results from CMA, 118 proceeded to trio ES. Five (4.2%; 5/118) disease-causing variants across five unrelated fetuses, involving four genes: DLL1, KMT2D, PTEN and PRKG1, with two cases harboring distinct pathogenic variants in KMT2D. Following rigorous phenotype-genotype correlation assessment, only the two KMT2D variants were deemed clinically attributable, resulting in an attributable diagnostic yield of 1.7% (2/118). The remaining three variants were classified as incidental findings. With the exception of the PRKG1 variant, which was inherited from the mother, the remaining four variants were confirmed as de novo.
CONCLUSION: Our results should raise clinical awareness among obstetricians and maternal-fetal medicine specialists regarding the potential syndromic associations of pelvic kidney.